Plus Therapeutics, Inc. (PSTV)
0.2904
-0.18
(-38.23%)
USD |
NASDAQ |
Jan 14, 16:00
0.3148
+0.02
(+8.40%)
After-Hours: 20:00
Plus Therapeutics EPS Diluted (Quarterly): -0.0412 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -0.3495 |
| InfuSystem Holdings, Inc. | 0.1078 |
| Xtant Medical Holdings, Inc. | 0.0087 |
| VolitionRX Ltd. | -0.0497 |
| Catheter Precision, Inc. | -1.705 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.423M |
| Revenue (Quarterly) | 1.397M |
| Total Expenses (Quarterly) | 5.82M |
| Enterprise Value | 23.33M |
| Gross Profit Margin (Quarterly) | 93.84% |
| Profit Margin (Quarterly) | -316.6% |
| Earnings Yield | -655.7% |
| Normalized Earnings Yield | -511.91 |